Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction

Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction

BackgroundThe correlation between echocardiographic parameters and hemodynamics data in patients with heart failure with preserved ejection fraction (HFpEF) is unclear. It is important to find a non-invasive echocardiographic parameter for predicting exercise pulmonary capillary wedge pressure (PCWP...

Full description

Bibliographic Details
Main Authors:	Zheng-Wei Chen, Chen-Yu Huang, Jen-Fang Cheng, Ssu-Yuan Chen, Lian-Yu Lin, Cho-Kai Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-12-01
Series:	Frontiers in Physiology
Subjects:	HFpEF stress Doppler echocardiography hemodynamics GLS tissue Doppler and strain echocardiography
Online Access:	https://www.frontiersin.org/article/10.3389/fphys.2019.01470/full

Similar Items

Right Ventricular‐Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction
by: Zheng‐Wei Chen, et al.
Published: (2024-01-01)

Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study
by: Daniele Pastori, et al.
Published: (2021-07-01)

Haemodynamic validation of the three‐step HFA‐PEFF algorithm to diagnose heart failure with preserved ejection fraction
by: Ettore Lanzarone, et al.
Published: (2023-08-01)

Different determinants of exercise capacity in HFpEF compared to HFrEF
by: Arlind Batalli, et al.
Published: (2017-04-01)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
by: Bin Dong, et al.
Published: (2022-11-01)

Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection Fraction
by: Gulinu Maimaituxun, et al.
Published: (2021-01-01)

POCUS for Diastolic Dysfunction: A Review of the Literature
by: Samantha King, et al.
Published: (2023-04-01)

The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
by: Becker Al-Khayatt, et al.
Published: (2024-05-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01)

Comparison of global and regional myocardial strains in patients with heart failure with a preserved ejection fraction vs hypertension vs age-matched control
by: Hyung Yoon Kim, et al.
Published: (2020-11-01)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
by: Clement Lau, et al.
Published: (2022-07-01)

Biventricular longitudinal strain as a predictor of functional improvement after D-shant device implantation in patients with heart failure
by: Yi Zhou, et al.
Published: (2023-04-01)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
by: Ahmed Hamam, et al.
Published: (2022-12-01)

Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
by: Gabrielle Fusco‐Allison, et al.
Published: (2021-10-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
by: Yohei Sotomi, et al.
Published: (2021-06-01)

Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions
by: Chung-Lieh Hung, et al.
Published: (2013-03-01)

Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
by: Alberico Del Torto, et al.
Published: (2022-03-01)

Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study
by: Ravi V. Shah, et al.
Published: (2023-11-01)

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
by: Kramer J. Wahlberg, et al.
Published: (2024-01-01)

Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data
by: Nazli Farajidavar, et al.
Published: (2022-12-01)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
by: Peisen Huang, et al.
Published: (2021-06-01)

D‐dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes
by: Liyan Huang, et al.
Published: (2022-10-01)

Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats
by: Jiung-Pang Huang, et al.
Published: (2022-07-01)

Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
by: Elisabeth A. Jalink, et al.
Published: (2024-01-01)

The value of echocardiographic measurement of epicardial adipose tissue in heart failure patients
by: Gijs vanWoerden, et al.
Published: (2022-04-01)

p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
by: Xiaonan Chen, et al.
Published: (2022-06-01)

Exploring the impact of left ventricular diastolic dysfunction on postoperative cardiac surgery outcomes, with a focus on sex disparities: a comprehensive literature review
by: T. Ludden, et al.
Published: (2023-11-01)

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies
by: You Deng, et al.
Published: (2024-01-01)

Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
by: Alberto Palazzuoli, et al.
Published: (2023-01-01)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
by: Mariëlle Scheffer, et al.
Published: (2020-12-01)

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
by: José M. Inácio, et al.
Published: (2023-07-01)

Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas
by: Navkaranbir S. Bajaj, et al.
Published: (2020-08-01)

The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction
by: Takashi Komorita, et al.
Published: (2020-08-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
by: Kyle B. LaPenna, et al.
Published: (2021-03-01)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
by: Arjun K. Pandey, et al.
Published: (2022-04-01)

Early Hemodynamic Changes following Surgical Ablation of the Right Greater Splanchnic Nerve for the Treatment of Heart Failure with Preserved Ejection Fraction
by: Piotr Gajewski, et al.
Published: (2022-02-01)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
by: Zhen Hui Peh, et al.
Published: (2023-06-01)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-10-01)

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
by: Masahiro Seo, et al.
Published: (2023-04-01)

Inhalation of Ultrafine Zinc Particles Impaired Cardiovascular Functions in Hypertension-Induced Heart Failure Rats With Preserved Ejection Fraction
by: Fangbo Bing, et al.
Published: (2020-01-01)